Unanswered questions regarding the management of sunitinib-induced hypothyroidism
- 23 October 2007
- journal article
- Published by Springer Nature in Nature Clinical Practice Oncology
- Vol. 4 (12) , 674
- https://doi.org/10.1038/ncponc0998
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Sunitinib Induces Hypothyroidism in Advanced Cancer Patients and May Inhibit Thyroid Peroxidase ActivityThyroid®, 2007
- RETRACTED: Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptoticSteroids, 2007
- Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With SunitinibJNCI Journal of the National Cancer Institute, 2007
- Single-Dose Rexinoid Rapidly and Specifically Suppresses Serum Thyrotropin in Normal SubjectsJournal of Clinical Endocrinology & Metabolism, 2007
- Influence of L-Thyroxine Administration on Poor-platelet Plasma VEGF Concentrations in Patients with Induced Short-term Hypothyroidism, Monitored for Thyroid CarcinomaEndocrine Journal, 2007
- Phase II Trial of Bexarotene Capsules in Patients With Advanced Non–Small-Cell Lung Cancer After Failure of Two or More Previous TherapiesJournal of Clinical Oncology, 2006
- Association Between Development of Hypothyroidism and Improved Survival in Patients With Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2006
- VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculatureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Imatinib induces hypothyroidism in patients receiving levothyroxineClinical Pharmacology & Therapeutics, 2005
- Subclinical Thyroid DiseaseJAMA, 2004